EUVIMEDEUVIMED entdecken
Crossref

Therapeutic Potential of Mesenchymal Stem Cell‐Conditioned Medium via Macrophage Subset Regulation in a Mouse Model of Arthritis‐Associated Pain

Wataru Nemoto iD, Kotaro Yamada, Ribou Shiga, Nanami Ikeda, Noa Suzuki, Yukari Seo, Tasuku Kawano, Tomoko Takahashi, Ryota Yamagata, Gi-Wook Hwang, Shigeyuki Ota, Osamu Nakagawasai und 1 weitere

European Journal of Neuroscience · 2025

DOI: 10.1111/ejn.70296 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Neuroscience, 2025. Verfasst von Wataru Nemoto und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pharmacology, Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, Sendai, Japan. Hauptthemen laut MEDLINE: Macrophages, Mesenchymal Stem Cells, Arthritis, Experimental, Hyperalgesia. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science, Collaborative research fund from Rohto Pharmaceutical Co. Ltd.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteoarthritis (OA) is a leading cause of chronic pain and disabilities. Current treatments offer limited efficacy and are often associated with adverse effects. Therefore, novel therapeutic strategies are urgently needed. Mesenchymal stem cell‐conditioned medium (MSC‐CM) possesses immunomodulatory properties and has been shown to suppress macrophage (MΦ) activity, which plays a key role in arthritis pain. However, the effect of MSC‐CM‐mediated MΦ regulation on arthritis‐induced pain remains unclear. In this study, we investigated the analgesic effects of MSC‐CM in a mouse model of adjuvant‐induced arthritis (AIA), established by the injection of complete Freund's adjuvant (CFA), and examined the involvement of MΦs in mediating these effects. MSC‐CM was administered as a single intravenous injection via the tail vein 1 d after the CFA injection. Mechanical and thermal hyperalgesia were evaluated using von Frey filament and the Hargreaves test, respectively. MSC‐CM significantly alleviated both mechanical and thermal hyperalgesia but had no effect during the recovery phase. On Day 3 post‐CFA injection, when the analgesic effect was most pronounced, flow cytometric analysis revealed that MSC‐CM selectively reduced pro‐inflammatory M1 MΦs at the site of inflammation without affecting pan‐MΦs or anti‐inflammatory M2 MΦ populations. Additionally, depletion of MΦs using clodronate liposomes attenuated hyperalgesia in AIA mice. These findings indicate that hyperalgesia in AIA mice was MΦ‐dependent and that MSC‐CM exerted its antihyperalgesic effects by suppressing MΦ activation at inflammatory sites, highlighting its potential as a novel therapeutic approach for inflammatory pain.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MacrophagesMesenchymal Stem CellsArthritis, ExperimentalHyperalgesiaPainAnimalsCulture Media, ConditionedMiceMaleMice, Inbred C57BLFreund's AdjuvantDisease Models, Animal

Stichwörter der Autor:innen

complete Freund's adjuvanthyperalgesiaimmunityinflammatory pain

Substanzen

Culture Media, ConditionedFreund's Adjuvant

Autor:innen und Institutionen

  • Division of Pharmacology, Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
  • Regulatory Affairs Promotion Division, ROHTO Pharmaceutical Co. Ltd., Osaka, Japan.
  • Division of Pathophysiology, Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
  • Division of Environmental and Health Sciences, Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
  • Regenerative Medicine Research & Planning Division, ROHTO Pharmaceutical Co. Ltd., Osaka, Japan.

ORCID-Profile: Wataru Nemoto, Koichi Tan-No

Förderung

  • Japan Society for the Promotion of Science
  • Collaborative research fund from Rohto Pharmaceutical Co. Ltd

Zitieren

APA

Nemoto, W., Yamada, K., Shiga, R., Ikeda, N., Suzuki, N., Seo, Y., Kawano, T., Takahashi, T., Yamagata, R., Hwang, G. W., Ota, S., Nakagawasai, O., & Tan-No, K. (2025). Therapeutic Potential of Mesenchymal Stem Cell‐Conditioned Medium via Macrophage Subset Regulation in a Mouse Model of Arthritis‐Associated Pain. European Journal of Neuroscience. https://doi.org/10.1111/ejn.70296

Vancouver

Nemoto W, Yamada K, Shiga R, Ikeda N, Suzuki N, Seo Y, et al. Therapeutic Potential of Mesenchymal Stem Cell‐Conditioned Medium via Macrophage Subset Regulation in a Mouse Model of Arthritis‐Associated Pain. European Journal of Neuroscience. 2025. doi:10.1111/ejn.70296

BibTeX
@article{Nemoto2025,
  author = {Nemoto, Wataru and Yamada, Kotaro and Shiga, Ribou and Ikeda, Nanami and Suzuki, Noa and Seo, Yukari and Kawano, Tasuku and Takahashi, Tomoko and Yamagata, Ryota and Hwang, Gi-Wook and Ota, Shigeyuki and Nakagawasai, Osamu and Tan-No, Koichi},
  title = {Therapeutic Potential of Mesenchymal Stem Cell‐Conditioned Medium via Macrophage Subset Regulation in a Mouse Model of Arthritis‐Associated Pain},
  journal = {European Journal of Neuroscience},
  year = {2025},
  doi = {10.1111/ejn.70296}
}
Kostenlos starten →